SHANDONG, China, Jan. 25 /PRNewswire-Asia-FirstCall/ -- China YCT International Group, Inc. ("China YCT" or the "Company") (OTC Bulletin Board: CYIG) today announced that on December 23, 2009 the State Intellectual Property Office of the People's Republic of China approved the patent application of its operating subsidiary, Shandong Spring Pharmaceutical Co., Ltd., for "a unique method of making ginkgo tea, and the manufacturing technology." This patent represents a key addition to the Company's growing intellectual property portfolio.
China YCT's technology improves the methods traditionally employed in the gingko tea health care products industry, and provides a faster, more efficient method of offering the public gingko tea. Studies have shown that Gingko tea has memory-enhancing benefits for people. "Our method of producing gingko tea increases the memory-enhancing ingredients as compared to the traditional gingko products, so our products will provide increased resistance to memory loss, whether short- or long-term," said Mr. Tinghe Yan, Chairman and CEO of China YCT.
The Company's new products can slow down the platelet activating factor (PAF) to stop it from over stimulation. Medical studies have shown that excess production of PAF can result in various inflammation-related diseases, including damage to the brain. In addition, like all other properly made gingko tea products, the Company's new products help reduce cholesterol and aid in blood circulation, thus reducing the risk of heart disease.
In order to maximize the benefits of gingko, the Company's R&D team developed a new and unique production method. "Our unique new gingko tea products, which will provide many physical benefits to people that other gingko teas cannot, give us confidence that we can make successful inroads into China's healthcare market in the years ahead," said Mr. Tinghe Yan.
"Receiving this patent is another important milestone, as China YCT accelerates its strategic growth plan," said Mr. Yan. "We're committed to developing innovative products based on our experience in the gingko healthcare products industry. We intend this to be the first in a series of technological breakthroughs, and we will continue to seek legal protection for these innovations. The benefits of our new products enhance the value of the Company as a whole," Mr. Yan added.
About China YCT International Group, Inc.
Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use chemical products, ginkgo glycoside products and biological medicines.
Safe Harbor Statement
The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors described from time to time in our filings with the Securities and Exchange Commission under the heading "Risk Factors" could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this press release, and we undertake no obligation to publicly update such forward- looking statements to reflect subsequent events or circumstances.
For further information, contact: Zecheng Shao Phone: +86-537-426-8260 Fax: +86-537-426-8292
SOURCE China YCT International Group, Inc.
|SOURCE China YCT International Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved